Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionBeacon Pointe Advisors, LLC
Latest Disclosed Ownership84,517 shares
Latest Disclosed Value $ 12,909,914
Beacon Pointe Advisors, LLC reports 26.94% increase in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On May 15, 2026 - Beacon Pointe Advisors, LLC filed a 13F-HR form disclosing ownership of 84,517 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $10,860,434 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 18, 2026 disclosing 66,582 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 26.94% during the quarter. The current value of the position is $10,226,557 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 84,517 17,935 26.94 12,910 40.64 0.0683
2026-02-18 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 66,582 2,801 4.39 9,180 12.23 0.0644
2025-11-14 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 63,781 2,676 4.38 8,179 10.62 0.0693
2025-08-13 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 61,105 2,638 4.51 7,394 13.46 0.0772
2025-05-13 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 58,467 14,626 33.36 6,518 52.77 0.0732
2025-02-14 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 43,841 -4,117 -8.58 4,266 -22.66 0.0473
2024-11-14 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 47,958 2,035 4.43 5,516 12.85 0.0636
2024-08-12 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 45,923 1,209 2.70 4,889 13.02 0.0578
2024-05-14 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 44,714 8,085 22.07 4,325 16.96 0.0481
2024-02-08 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 36,629 4,304 13.31 3,698 12.33 0.0442
2023-11-14 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 32,325 21,231 191.37 3,293 194.19 0.0410
2023-08-14 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 11,094 2,053 22.71 1,119 34.66 0.0183
2023-05-12 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 9,041 -5,835 -39.22 832 -38.40 0.0142
2023-02-14 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 14,876 -131 -0.87 1,350 18.33 0.0262
2022-11-09 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 15,007 -2,729 -15.39 1,140 -24.05 0.0255
2022-08-11 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 17,736 -14,535 -45.04 1,501 -47.00 0.0317
2022-05-17 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 32,271 19,561 153.90 2,832 154.68 0.0388
2022-02-14 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 12,710 -653 -4.89 1,112 1.74 0.0290
2021-11-15 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 13,363 -804 -5.68 1,093 -15.47 0.0270
2021-08-17 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 14,167 7,596 115.60 1,293 129.66 0.0458
2021-05-18 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 6,571 -6,462 -49.58 563 -54.30 0.0346
2021-02-12 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 13,033 1,889 16.95 1,232 27.14 0.0843
2020-11-16 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 11,144 -1,455 -11.55 969 -11.75 0.0937
2020-08-14 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 12,599 2,562 25.53 1,098 32.93 0.1100
2020-05-15 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 10,037 10,037 826 0.1316
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.